FI912240A0 - Antitrombiner. - Google Patents

Antitrombiner.

Info

Publication number
FI912240A0
FI912240A0 FI912240A FI912240A FI912240A0 FI 912240 A0 FI912240 A0 FI 912240A0 FI 912240 A FI912240 A FI 912240A FI 912240 A FI912240 A FI 912240A FI 912240 A0 FI912240 A0 FI 912240A0
Authority
FI
Finland
Prior art keywords
gly
glu
cys
asp
indicates
Prior art date
Application number
FI912240A
Other languages
English (en)
Finnish (fi)
Inventor
Roy Sawyer
Christopher Powell-Jones
Anthony Atkinson
Asgar Electricwala
Original Assignee
Biopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Ltd filed Critical Biopharm Ltd
Publication of FI912240A0 publication Critical patent/FI912240A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
FI912240A 1988-11-11 1991-05-09 Antitrombiner. FI912240A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888826428A GB8826428D0 (en) 1988-11-11 1988-11-11 Antithrombin
PCT/GB1989/001345 WO1990005143A1 (en) 1988-11-11 1989-11-13 Anti-thrombins

Publications (1)

Publication Number Publication Date
FI912240A0 true FI912240A0 (fi) 1991-05-09

Family

ID=10646705

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912240A FI912240A0 (fi) 1988-11-11 1991-05-09 Antitrombiner.

Country Status (16)

Country Link
US (1) US5472942A (de)
EP (1) EP0373767B1 (de)
JP (1) JP2865345B2 (de)
KR (1) KR0153774B1 (de)
AT (1) ATE111484T1 (de)
AU (1) AU636857B2 (de)
CA (1) CA2002924C (de)
DE (1) DE68918246T2 (de)
DK (1) DK173077B1 (de)
FI (1) FI912240A0 (de)
GB (1) GB8826428D0 (de)
HU (1) HUT62016A (de)
IE (1) IE64652B1 (de)
RU (1) RU2050160C1 (de)
WO (1) WO1990005143A1 (de)
ZA (1) ZA898655B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721098A (en) * 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9007879D0 (en) * 1990-04-06 1990-06-06 Biopharm Ltd Treatment of thrombotic events
IL101062A0 (en) * 1991-02-28 1992-11-15 Erba Carlo Spa Anti-thrombin polypeptides and their preparation
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US7534567B2 (en) * 1992-03-04 2009-05-19 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
IT1266561B1 (it) * 1993-07-22 1997-01-09 Mini Ricerca Scient Tecnolog Analoghi di un polipeptide anti-trombinico e procedimento per la loro preparazione
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US6008320A (en) * 1995-04-27 1999-12-28 Korea Advanced Institute Of Science And Technology Elastase inhibitor and process for preparing the same
US6077825A (en) 1997-03-13 2000-06-20 Auburn University Antithrombin protein and DNA sequences from black fly
WO2005079474A2 (en) * 2004-02-17 2005-09-01 The Regents Of The University Of California Detection of nucleic acid sequence differences by comparative genomic hybridization
US8784896B2 (en) 2012-09-17 2014-07-22 Biopep Solutions, Inc Antioxidant therapy with a whole, leech saliva extract
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法
CN115677850B (zh) * 2021-07-24 2024-03-08 王大勇 具备较强抗凝血活性的医蛭基因突变水蛭素及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
US5139944A (en) * 1985-08-10 1992-08-18 Biophram (Uk) Limited Collagen-specific enzyme with platelet aggregation inhibition properties
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
EP0333356A3 (de) * 1988-03-04 1990-12-19 Biogen, Inc. Hirudin-Peptide
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.

Also Published As

Publication number Publication date
RU2050160C1 (ru) 1995-12-20
CA2002924C (en) 1999-08-03
ATE111484T1 (de) 1994-09-15
DK173077B1 (da) 1999-12-20
CA2002924A1 (en) 1990-05-11
WO1990005143A1 (en) 1990-05-17
ZA898655B (en) 1990-08-29
JP2865345B2 (ja) 1999-03-08
GB8826428D0 (en) 1988-12-14
EP0373767A1 (de) 1990-06-20
AU4522589A (en) 1990-05-28
DE68918246T2 (de) 1995-02-16
IE64652B1 (en) 1995-08-23
HUT62016A (en) 1993-03-29
DK87891A (da) 1991-06-21
DK87891D0 (da) 1991-05-10
US5472942A (en) 1995-12-05
AU636857B2 (en) 1993-05-13
KR900701832A (ko) 1990-12-04
JPH04502907A (ja) 1992-05-28
HU896934D0 (en) 1991-07-29
DE68918246D1 (de) 1994-10-20
EP0373767B1 (de) 1994-09-14
KR0153774B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
FI912240A0 (fi) Antitrombiner.
ES2103305T3 (es) Produccion de inhibidor de interleuquina-1 humana recombinada.
ES8707551A1 (es) Procedimiento para preparar peptidos triofluormetilcetona-sustituidos
ATE155486T1 (de) Zyklische peptide und ihre verwendung
ATE124997T1 (de) Enzymatische entfernung einer aminoterminalen proteinsequenz.
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
EP0225020A3 (de) Peptide, welche in der Sequenz Einheiten von Aminosäureresten 17 bis 24 von VIP enthalten
DE68917837D1 (de) Peptid-Verbindungen.
DK102892D0 (da) Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter
EP0333071A3 (de) Polypeptide, deren Methoden zur Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und Verwendung
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
AU3902489A (en) Non-glycosylated, recombinant human IL2 in the reduced form, the process for obtaining it and its use as a medicament
FI93843C (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
DK0378432T3 (da) Peptider, deres anvendelse til inhibering af modningen af T-lymfocytter og aktiviteten af makrofager samt fremgangsmåder til deres fremstilling
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
AU3934689A (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA2247998A1 (en) Fragments of cr1 and their use
ECSP972344A (es) Proteinas antiobesidad

Legal Events

Date Code Title Description
FD Application lapsed